Skip to content
10-K

Annual Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-12-000089

← back to feed
Filed
Mar 29, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Dec 31, 2011 150M sh
Operating Cash Flow FY 2011 · Dec 31, 2011 −$1.07M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$72.59K
Sga Expense FY 2011 · Dec 31, 2011 $1.75M
Sga Expense FY 2011 · Dec 31, 2010 $432K
Net Income FY 2011 · Dec 31, 2011 −$1.94M
Net Income FY 2011 · Dec 31, 2010 −$441.29K
Stockholders Equity FY 2011 · Dec 31, 2010 −$1.52M
Total Liabilities FY 2011 · Dec 31, 2010 $1.91M
Current Assets FY 2011 · Dec 31, 2010 $11.03K
Total Assets FY 2011 · Dec 31, 2010 $384.22K
Cash And Equivalents FY 2011 · Dec 31, 2009 $10.6K